Weekly Recap | Regeneron Pharma -5.59%, class action deadline passesWeekly Review·Sep 12 at 06:39 AMREGN+0.06%
Weekly Recap | Regeneron Pharma +4.22%, closing in on record highsWeekly Review·Sep 5 at 07:49 AMREGN+0.06%
Weekly Recap | Regeneron Pharma -4.78%, consensus target above spotWeekly Review·Aug 29 at 06:22 AMREGN+0.06%
Weekly Recap | Regeneron Pharma +3.8%, FDA clears rare-disease drugWeekly Review·Aug 22 at 05:35 AMREGN+0.06%
